Clinical Trials Browser

Phase 1/2 × INDUSTRY × Dianhydrogalactitol × Clear all

NCT01478178 2025-08-29

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

Phase 1/2 Completed

Brain Neoplasms, Glioblastoma, Glioma

NCT03281681 2019-10-18

REPROVe

Phase 1/2 Withdrawn

Ovarian Neoplasms